Summary: Steroid sulfatase (STS) is a microsomal enzyme responsible for the formation of 3b-hydroxysteroid from the corresponding sulfate conjugates. Screening of all exons, exon-intron boundaries and the 5?-flanking region of the STS gene in 93 healthy Japanese individuals was carried out. Among seven single nucleotide polymorphisms (SNPs) identified in this study, six were novel, including one in the untranslated region of exon 1, one in exon 10, and four in the 5?-flanking region. The nonsynonymous SNP (1647GÀA) in exon 10 caused amino-acid replacement, Val476Met, with a frequency of 0.014. The allele frequencies of the other SNPs were 0.071 for 155GÀA, 0.007 for -21GÀA, 0.014 for -1117TÀC, 0.106 for -1588GÀA, 0.007 for -2427GÀA and 0.007 for -2837TÀC.
Introduction
Steroid sulfatase (STS, EC 3.1.6.2, also known as aryl sulfatase C) is a membrane-associated enzyme localized on the endoplasmic reticulum; it hydrolyzes steroid sulfates, such as estrone sulfate and dehydroepiandrosterone sulfate, to their unconjugated forms. 1) STS is a member of a superfamily comprising 16 different mammalian sulfatases. 2) In humans, STS is expressed maximally in placenta 3) but is ubiquitously distributed in other tissues at low levels. 4) Human STS is synthesized as a membranebound precursor with an apparent molecular size of 63 kDa and is processed to a mature 61-kDa protein. 5) The deduced amino acid sequence of the mature enzyme consists of 583 amino acid residues. 6) Recent success in purification and crystallization of human placental STS 7) resulted in the determination of the three-dimensional structure of this enzyme. 8) The human STS gene (GenBank accession No. M23945) consists of 10 exons spread over 146 kb in the distal short arm of the X chromosome (Xp22.3). Complete loss of STS activity due to gene deletion or several point mutations of the STS gene results in X-linked ichthyosis (XLI), which is an X-linked disorder of cutaneous hyperkeratinization. 9, 10) Recent studies revealed that STS plays an important role in the progression of hormone-dependent carcinomas, such as an estrogen receptor-positive breast cancer. 11) In fact, a potential association has been reported in terms of STS activity in cancer cells and response to anti-estrogen agents. 12) Therefore, inhibition of STS is becoming an attractive therapeutic strategy for estrogen-dependent breast and endometrial cancers. 13, 14) Although several SNPs responsible for XLI have been reported, 15) there are few reports about information of genetic polymorphisms associated with change in STS activity to date.
In the present study, we searched for unidentified SNPs by PCR-SSCP followed by sequencing of all the exons and the 5?-flanking region (5?FR) on the STS gene from 93 healthy Japanese individuals. We discovered six novel SNPs located in 5?FR and in exons 1 and 10.
Materials and Methods
Human genomic DNA samples: Genomic DNA was isolated from whole blood provided by 93 unrelated Japanese healthy volunteers (45 male and 48 female volunteers). This study was approved by the life-ethics committee of Chiba University School of Medicine (approved no. 5-24), and written, informed consent was ob- tained from all volunteer blood donors. PCR-SSCP analysis: The primers used for DNA amplification were designed on the basis of the sequence of the STS gene obtained from GenBank (accession no. NT_167197.1) and are listed in Table 1 . PCR was conducted in a reaction mixture of 25 mL containing 50 ng genomic DNA, 2.5 U Ex Taq HS (Takara Bio, Shiga, Japan), 2.5 mM MgCl2, and 0.2 mM dNTPs with 0.2 mM of each primer. PCR conditions consisted of an initial denaturation at 959 C for 3 min, followed by 30 cycles of denaturation at 959 C for 10 sec, annealing for 5 sec and extension at 729 C for 5 sec. Annealing temperatures are summarized in Table 1 . Single-strand conformation polymorphism (SSCP) analysis was performed according to essentially the same method as described previously 16) using a GeneGel Excel 12.5/24 (GE Healthcare, Tokyo, Japan). Nondenaturing electrophoresis was done at 209 C.
Sequencing analysis: DNA sequences were determined using a BigDye Terminator Cycle Sequencing Kit ver. 1.1 (Applied Biosystems, Foster City, CA) and an ABI Prism 310 Genetic Analyzer (Applied Biosystems) according to the manufacturers' instructions. The transcription start site is defined as -221 from the ATG codon for the translation initiating methionine.
17)
Genotyping: The allele frequencies of SNPs detected in this study were examined by the PCR-restriction fragment length polymorphism (PCR-RFLP) method. The sequence of primers, PCR conditions and restriction enzymes used in the analyses are summarized in Table 2 . Digested products were separated by 2.5-3.0% (w/v) agarose gel. 
Results and Discussion
The six novel SNPs in the STS gene found in this study are as follows: 1) SNP, 100315MatsumotoJ001; GENE NAME, STS;
ACCESSION NUMBER, NT_167197.1; LENGTH, 25 bases; 5?-TGAACAGAGGATG/AAACAAGTGA-AGT-3? 2) SNP, 100315MatsumotoJ002; GENE NAME, STS; ACCESSION NUMBER, NT_167197.1; LENGTH, 25 bases; 5?-AACTTCAACCCCG/ATGGGTTCCAA-CG-3? 3) SNP, 100315MatsumotoJ003; GENE NAME, STS;
ACCESSION NUMBER, NT_167197.1; LENGTH, 25 bases; 5?-AAGAGTGTCTCCG/ACCTCACATTA-TC-3? 4) SNP, 100315MatsumotoJ004; GENE NAME, STS;
ACCESSION NUMBER, NT_167197.1; LENGTH, ACCESSION NUMBER, NT_167197.1; LENGTH, 25 bases; 5?-GATCTGAATACAG/ACATGGGAAA-GTG-3? 6) SNP, 100315MatsumotoJ006; GENE NAME, STS;
ACCESSION NUMBER, NT_167197.1; LENGTH, 25 bases; 5?-ATTTGCTCTGAGG/ACCAGACTGTT-CC-3? Genetic polymorphisms in the postulated proximal promoter region (up to 3 kb from the transcription start site) and all 10 exons in the STS gene were investigated in genomic DNA isolated from 93 healthy Japanese volunteers. The seven SNPs detected in this study are summarized in Table 3 . Of these SNPs, six appear to be novel because these SNPs were not found in public databases such as JSNP (http://snp.ims.u-tokyo.ac.jp/) and dbSNP (http://www.ncbi.nlm.nih.gov/SNP/) on March 15, 2010. The electropherograms of the six novel SNPs are shown in Figure 1 . Since the STS gene is located on the X chromosome, the number of alleles investigated in this study was 141 (45 from the 45 male and 96 from the 48 female volunteers). The allele frequencies of the SNPs determined in this study are shown in Table 3 . The genotype frequencies were found to be in Hardy-Weinberg equilibrium, and no linkage disequilibrium among these SNPs was found.
It has been reported that the proposed negative regulatory region 17) and the minimum sequences required for promoter activity exist in ca. 200 bp (from -1032 to -1237) and 80 bp (from -1 to -80) upstream from the transcription start site, respectively. Since two novel SNPs, -1117TÀC (100315MatsumotoJ004) and -21GÀA (100315MatsumotoJ003), were found in these regions, these SNPs might have some effects on transcriptional activity.
On the other hand, the novel nonsynonymous SNP, 1647GÀA (Val476Met, 100315MatsumotoJ002) may alter catalytic activity, because most of the point mutations reported to affect STS activity are located in the Cterminal half polypeptide, which is thought to be important for substrate binding. 18) Further studies are being conducted in our laboratory to examine whether each SNP in 5?FR and the nonsynonymous SNP in exon 10 affect transcriptional and catalytic activities, respectively.
In conclusion, six novel SNPs (including a nonsynonymous SNP causing Val476Met) in the STS gene were identified in healthy Japanese subjects. These results may provide basic information on interindividual differences in STS activity in Japanese and probably also in Oriental populations.
